Atara, Pierre Fabre allege FDA about-face as agency hands down 2nd Ebvallo snub

12th January 2026 Uncategorised 0

With Ebvallo’s latest U.S. rejection, Atara Biotherapeutics and its partner Pierre Fabre Pharmaceuticals are accusing the FDA of pulling an about-face.

More: Atara, Pierre Fabre allege FDA about-face as agency hands down 2nd Ebvallo snub
Source: fierce